Marine bacteria require a significant amount of NaCl for optimal growth and have quite different physiological character from terrestrial counterparts. For example, marine bacteria possess a unique type ofNADH:quinone reductase, a membrane-bound enzymewhich takes part in the respiratory chain1}. This enzyme requires Na+for its activity and with its Na+-pumping activity generates sodium-motive force which enables these bacteria to live easily in the marine environment. This energy-acquisition system was found only in Gram-negative marine and moderately halophilic bacteria but not in halo-tolerant bacteria or archaea which also live in the environment with high salinity2).
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In this regard it is probable that marine bacteria produce unique metabolites by their unique metabolic pathways which do not occur in other microorganisms including extensively studied terrestrial microorganisms.
In the course of our searching project for useful compoundin the metabolites of marine bacteria, we have found and reported several unique compounds3'40.
Amongthem a marine bacterial strain Pseudoalteromonas sp. F-420 was found to produce an antibiotic compound named korormicin ( Fig. 1)5 ). This compound showed very interesting bioactivity, that is, it inhibited specifically the growth of Gram-negative marine and halophilic bacteria, whereas Gram-positive strains and nonhalophilic bacteria were insensitive to this compound. The data suggests that korormicin has some specific targets solely found in Gram-negative marine bacteria.
pp. 182 -185 In this study Na+-translocating NADH:quinone reductase (NQR) widely distributed in the Gram-negative marine and halophilic bacteria was selected as the first candidate target molecule of korormicin. This paper describes the result of the inhibition experiment.
Results and Discussion
The Na+-translocating NADH:quinone reductase (NQR) from the marine Vibrio alginolyticus is composed of 6 different subunits6 '7) and catalyzes two successive reactions8).
First, the FAD-containing subunit reacts with NADH and reduces the quinone substrate by a one-electron transfer pathway to produce semiquinone radicals. Then, semiquinone radicals are quickly converted to quinol by the action of other subunits. The latter, but not the former, reaction specifically requires Na+ for the activity and is directly linked to the extrusion ofNa+ from the cells. The former NADHdehydrogenase (NDH) activity could be measured from the decrease in
as the substrate. The total NADH:quinone reductase (NQR)activity could be measured from the reduction of ubiquinone-1 (Q-l) to ubiquinol-1. Thus, the effects ofkorormicin on the NDHand NQRactivities were examined as shown in Fig. 2a . Korormicin, up to lOOnM,did not affect the NDHactivity at all. On the other hand 1 nMkorormicin effectively inhibited NQR activity. This means that korormicin strongly inhibits the latter part of the NQRreaction that is directly linked to the Na+-pumping activity. Using the membrane fraction and the Na+-loaded cells of V. alginolyticus 1 38-2, Tokuda and Unemotoreported that 2-heptyl-4-hydroxyquinoline TV-oxide (HQNO) also inhibits NQR, but not NDH, activity9*. In our experiment using the purified enzyme preparation (Fig. 2b ) more than lOOnMHQNOwas needed to inhibit 50% of the NQRactivity, so the inhibitory activity of korormicin on NQRactivity was much more significant compared to that of HQNO. The NQRcomplex purified from V. alginolyticus had NDHand NQRactivities of 120 and 53 units/mg protein, respectively, and 0.12 ug protein of the enzyme was used for each assay. The modeof action ofkorormicin to the NQRactivity was investigated. As shown in Fig. 3a which provides the double-reciprocal plots, korormicin acted as a noncompetitive inhibitor for Q-l. From the secondary plots (Fig. 3b) , the inhibitor constants for the free enzyme (Ki) and the enzyme-substrate complex (Kii) were estimated to be 8.3.7 and 81.1 pM, respectively. Since Ki is almost identical to Kii, korormicin acts as a fully noncompetitive inhibitor for Q-l.
It is reported that wide variety of Gram-negative marine bacteria possess NQR10), but Gram-positive bacteria seem to lack this enzyme2). In the paper-disk method korormicin was a specific growth inhibitor against Gram-negative marine bacteria and Gram-posi-183 tive strains were resistant to this drug. On the other hand HQNOinhibited some Gram-positive bacteria as well as non-halophilic bacteria (Table 1) . Furthermore, someGram-negativemarine bacteria weresensitive to HQNO while others were not from the result of the paper-disk method. The wide antibacterial spectrum of HQNOwas described by Machan et aLxl\ Considering that HQNOis known to inhibit several enzymes including 5-lipoxygenase from rat12), mitochondrial complex I and III from beef heart12), and cytochrome b/cx complex from Rhodospirillum rubrum13\ this compoundmay attack some other target molecule insensitive to korormicin on the Gram-positive bacteria.
It is interesting that some Gram-negative marine bacteria were found insensitive to HQNO by the paper-disk method. Although korormicin and HQNOmay diffuse differently in the agar plate, it could be said that these two antibiotics act on the intact cells with different manneror that some living cells are able to degradate HQNOin the medium.
In conclusion we demonstrated that korormicin, a specific inhibitor against Gram-negative marine bacteria produced by the marine bacterium Pseudoalteromonas sp. F-420, strongly inhibits the respiration-coupled NQR complex purified from V. alginolyticus 138-2. It inhibits the NQR activity of the complex in the fully noncompetitive mode, but does not affect the NDH activity. The inhibition constant was around 80pM using Q-l as quinone substrate. In comparison with the known NQRinhibitor HQNO,inhibition activity of korormicin against NQRwas much higher, although both compounds inhibited the quinol formation reaction.
As HQNO is known to inhibit bacteria other than Gram-negative marine species and enzymes other than NQR,korormicin can be said to be a more selective inhibitor. Recently, the existence of NQR in nonhalophilic bacterium Haemophilus influenzae was reported14). The action of korormicin on NQRfrom this strain is to be investigated. FEB. 1999 Experimental Chemicals and EnzymePreparation Q-l and HQNOwere purchased from Sigma Chemical Co. (St. Louis, MO). Korormicin from Pseudoalteromonas sp. F-420 was prepared as reported5). Purification of NQR complex from V. alginolyticus 138-2 was described elsewhere7). Purified NQR complex was resuspended in 10mM Tris-HCl (pH 7.6) containing 10mM NaCl, 0.1mM EDTA, 10% (w/v) glycerol, 0.2mg/ml L-phosphatidylcholine from soybean, and 0.1% (w/v) Liponox DCH8).
Enzyme Assays and Kinetic Analyses
The NDHand NQRactivities were measured by the method described by Nakayama et al.1] . One unit of enzymeactivity is defined as the amount of enzyme catalyzing the oxidation of 1fimol NADH or the reduction of 1 /^mol Q-l in 1 minute at 30°C. For kinetic analyses, the line of best fit for each set of double-reciprocal plots and kinetic constants were calculated using the program EnzymeKinetics (Trinity Software, Campton, NH).
